Contents
Exploring Hematopoietic Cell Transplantation in CML Treatment
Published: Jun 17, 2024
Hematopoietic cell transplantation (HCT) offers a potential cure for some Chronic Myeloid Leukemia (CML) patients. This article explains what HCT involves and when it might be considered as a treatment option.
What is Hematopoietic Cell Transplantation?
HCT is a procedure that replaces diseased bone marrow with healthy cells from a donor. It's primarily considered for patients with advanced CML who haven't responded to other treatments. The procedure involves intensive chemotherapy and/or radiation, followed by the infusion of healthy donor cells to restore normal blood cell production.
Who Can Benefit from HCT?
HCT is not for everyone; it's usually reserved for medically-fit patients with advanced CML or those resistant to multiple TKIs. Factors like the patient's age, overall health, and availability of a suitable donor are crucial in determining eligibility. While HCT offers a chance for a cure, it also comes with significant risks, such as graft-versus-host disease.
Risks and Considerations
HCT carries risks like infection, organ damage, and graft-versus-host disease, where the donor cells attack the recipient's body. Long-term follow-up is essential to manage these risks and monitor for complications. Despite its challenges, HCT remains a valuable option for certain CML patients.
Frequently Asked Questions
HCT is a procedure to replace diseased bone marrow with healthy donor cells.
Eligibility depends on factors like disease stage, patient health, and donor availability.
Risks include infection, organ damage, and graft-versus-host disease.
A Critical Decision
HCT offers a potential cure for CML, but it requires careful consideration of risks and benefits.
References
- Marin D, Milojkovic D, Olavarria E, et al. European LeukemiaNet criteria for failure or suboptimal response. Blood 2008; 112:4437.
- Hematopoietic cell transplantation in chronic myeloid leukemia. Available at: https://www.uptodate.com/contents/hematopoietic-cell-transplantation-in-chronic-myeloid-leukemia
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
Top licensed doctors
Available in all 50 states
Full service care
Prescriptions, referrals & treatment
No insurance needed
All notes available in Doctronic
15-min consultation. No hidden costs.
AI Doctor Visit Required
Please Chat With Our AI Doctor First
Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?